Boai NKY Pharmaceuticals Ltd (300109) — Cash Flow Reinvestment Rate
Boai NKY Pharmaceuticals Ltd (300109) has a Cash Flow Reinvestment Rate of 0.30x as of September 2025, reinvesting CN¥41.41 Million (capex CN¥41.41 Million ) from operating cash flow of CN¥139.46 Million. Explore Boai NKY Pharmaceuticals Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Boai NKY Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Boai NKY Pharmaceuticals Ltd across 18 annual periods. Also explore 300109 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Boai NKY Pharmaceuticals Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Boai NKY Pharmaceuticals Ltd. For live market cap and broader valuation context, see 300109 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥265.14 Million | CN¥338.11 Million | CN¥220.42 Million | ▼ -42.6% |
| 2024 | 1.37x | CN¥349.68 Million | CN¥256.03 Million | CN¥274.68 Million | ▼ -27.7% |
| 2023 | 1.89x | CN¥922.52 Million | CN¥488.25 Million | CN¥377.88 Million | ▲ +70.8% |
| 2022 | 1.11x | CN¥278.44 Million | CN¥251.77 Million | CN¥266.00 Million | ▼ -89.6% |
| 2021 | 10.68x | CN¥463.85 Million | CN¥43.44 Million | CN¥228.32 Million | ▲ +2487.3% |
| 2020 | 0.41x | CN¥110.14 Million | CN¥266.87 Million | CN¥99.24 Million | ▼ -85.8% |
| 2019 | 2.91x | CN¥231.96 Million | CN¥79.64 Million | CN¥142.35 Million | ▼ -60.7% |
| 2018 | 7.41x | CN¥361.81 Million | CN¥48.81 Million | CN¥124.37 Million | ▼ -11.8% |
| 2017 | 8.40x | CN¥397.23 Million | CN¥47.28 Million | CN¥129.23 Million | ▲ +509.6% |
| 2016 | 1.38x | CN¥157.33 Million | CN¥114.14 Million | CN¥48.47 Million | ▲ +118.3% |
| 2015 | 0.63x | CN¥40.48 Million | CN¥64.12 Million | CN¥40.48 Million | ▼ -37.6% |
| 2014 | 1.01x | CN¥47.11 Million | CN¥46.60 Million | CN¥47.11 Million | ▼ -34.0% |
| 2013 | 1.53x | CN¥35.47 Million | CN¥23.17 Million | CN¥35.47 Million | ▼ -65.3% |
| 2012 | 4.41x | CN¥90.96 Million | CN¥20.65 Million | CN¥90.96 Million | ▼ -83.4% |
| 2011 | 26.46x | CN¥104.29 Million | CN¥3.94 Million | CN¥104.29 Million | ▲ +1144.2% |
| 2010 | 2.13x | CN¥21.38 Million | CN¥10.05 Million | CN¥21.38 Million | ▲ +140.5% |
| 2009 | 0.88x | CN¥25.27 Million | CN¥28.57 Million | CN¥25.27 Million | ▲ +77.3% |
| 2007 | 0.50x | CN¥4.77 Million | CN¥9.56 Million | CN¥4.77 Million | — |